Are you or someone you care about wondering if therapy might be helpful? Maybe you've thought, "I don't want to feel like this anymore, but I don't know what to do," or "Something just doesn’t feel ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, today announced the ...

Federal regulators said Thursday that they have given Pathwork Diagnostics of Sunnyvale permission to begin selling a new genetic test to determine what type of cancer cells are in a malignant tumor.

Whether you’re a teenager, or raising one, adolescence is no joke. This transitional period can test relationship limits and leave teens and parents feeling hurt, confused, scared, and an array of ...

Affymetrix Inc. and PathWork Informatics Inc. have announced that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic ...

Pathwork Diagnostics Inc., has announced that it has entered into a research collaboration with Novartis. The parties intend to discover clinically meaningful biomarker signatures that can serve as ...

Redwood City, CA, October 30, 2012 – Pathwork Diagnostics, Inc., the innovator of the Pathwork® Tissue of Origin Test and a pioneer in creating genomics-based diagnostics in oncology, today announced ...

SUNNYVALE, Calif., Sept. 4 Pathwork Diagnostics, amolecular diagnostics company focused on oncology, announced the closing todayof a $20 million financing led by Abingworth. The announcement came on ...

Pathwork Diagnostics, a Sunnyvale, Calif.-based maker of cancer diagnostic tets, has raised $20 million in a second round of funding. The round was led by new investor Abingworth Management, with ...